You are here
WBR technology increases patient safety and comfort, reduces nuclear radiation doses, and shortens scan times.
TUCSON, Ariz., June 23, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced the introduction of its Tucson‑based VERI/O laboratory service, offering laboratory support for its biopharma clients in biomarker research and companion diagnostic development. The VERI/O laboratory service formalizes and expands HTG’s traditional service offerings, including molecular profiling of retrospective cohorts to support development of targeted and immuno-oncology therapies, building custom research-use-only (RUO) assays to support early stage clinical programs, and developing companion diagnostic assays for use in Phase III registration trials.
MR Solutions, which introduced cryogen-free MRI scanners in 2012, is now offering a choice of two cryogen-free preclinical scanner ranges – the Flexiscan and Powerscan. The Flexiscan range is available with multi-modality accessories which can be mixed and matched according to research requirements. It is a flexible MRI system as it can incorporate integrated multi-modality options such as PET or SPECT. The Flexiscan system requires no specialist knowledge and can be operated simply by running pre-defined settings. There is no need to materially alter the parameters of the machine.
Beijing, China – HTA Co., Ltd. (HTA), the largest Chinese producer and distributor of radio-pharmaceuticals, and SHINE Medical Technologies (SHINE), a U.S. company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the companies have entered into a strategic agreement for the supply of molybdenum-99 (moly-99). The supply agreement, which marks HTA’s first with a U.S. supplier of moly-99, demonstrates both companies’ ongoing commitment to ensuring that the medical imaging community has reliable and secure access to moly-99 to meet the needs of patients.
Sunnyvale, Calif. – April 19, 2016 – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of its ImageXpress® Micro 4 High-Content Imaging System and revolutionary 3D image analysis capability in the latest version of MetaXpress® High-Content Image Acquisition and Analysis Software. For scientists conducting basic research or high-throughput screening, the ImageXpress System is a premiere, integrated and scalable toolset for optimal 3D image acquisition and analysis.
Knoxville, TN, UNITED STATES, March 18, 2016– ABT Molecular Imaging has partnered with a world-renowned oncology group to install the BG-75 Biomarker Generator System in The Republic of Cyprus. The BG-75 integrates a compact cyclotron, micro-chemistry, and automated quality control, to provide on-demand F-18 FDG production in one seamless solution to support the implementation of PET/CT.
MINNEAPOLIS, MN — (March 7, 2016) vRad (Virtual Radiologic), an affiliate of MEDNAX, Inc. (NYSE: MD) and the leading national teleradiology services and telemedicine company, today announced that it will showcase insights and best practices learned from a successful ICD-10 transition of 2,100+ client facilities during a live webinar on March 9, 2016 at 12:00 pm CT.
Amsterdam, The Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) and Allianz Worldwide Partners entered a partnership focusing on connected health solutions and services in Germany. The personal health programs* are designed for and tailored to motivate people to make healthy choices in their lifestyle, as active health management is necessary to stem the rising tide of chronic diseases. The health programs leverage Philips’ deep healthcare and consumer expertise are offered across employers as an instrument for occupational health, insurers and consumers.
A range of new assays has been released by Siemens for use on ADVIA Centaur and IMMULITE XPi 2000 systems.
Launch includes the first automated quantitative thyroid stimulating immunoglobulin (TSI) assay used in the diagnosis of Graves’ disease.
Selangor, Malaysia, Jan 29, 2016 - (ACN Newswire) - A biochemical compound developed as a radioactive tracer for cell proliferation shows increasing potential for use in cancer imaging, according to a recent paper published in the Pertanika Journal of Science & Technology.
UltraSPECT partners with HeartLight Pharmacy Services to help nuclear medicine facilities deliver reduced radiation dose, shortened scan time for patient, staff safety.
The Center for Molecular and Functional Imaging (CMFI) at the University of California – San Francisco will install the MILabs VECTor4CT in support of a large number of NIH funded research projects in the areas of oncology, neuroscience and drug discovery/development. The UCSF Department of Radiology and Biomedical Imaging invested significant resources in establishing the CMFI in 2003. Major research efforts at CMFI include translational nuclear medicine imaging research using both SPECT/CT and PET/CT. Utilization of the VECTor4CT will benefit from the CMFI installed medical cyclotron, state of the art radiopharmaceutical laboratory and in-house vivarium all under one roof.
Technavio’s latest chemicals and materials industry report covers the present scenario and growth prospects of the global helium market for the period 2016-2020. To calculate the market size, the report considers the revenue generated through the sales of helium in various applications. Various distribution modes for the gas were considered while arriving at the market size.
The QY Market research study, titled Worldwide , presents critical information and factual data about the Diagnostic Imaging Instrument market globally, providing an overall statistical study of the Diagnostic Imaging Instrument market on the basis of market drivers, Diagnostic Imaging Instrument Market limitations, and its future prospects. The prevalent global Diagnostic Imaging Instrument trends and opportunities are also taken into consideration in Diagnostic Imaging Instrument industry study.
The market report, titled , is an analytical research done by Market Research Store study based on the RIS Radiology Information System market, which analyzes the competitive framework of the RIS Radiology Information System industry worldwide. This report “Worldwide RIS Radiology Information System Market 2016” build by the usage of efficient methodical tools such SWOT analysis, the RIS Radiology Information System industrial 2016 study offers a comprehensive evaluation worldwide RIS Radiology Information System market.
Zotec Partners (Zotec), the industry leader in radiology revenue cycle and practice management services, is pleased to announce it will continue a Gold-level sponsorship commitment with the Radiology Business Management Association (RBMA) in 2016.
Ageing 2016 will be held from February 9 to 11, 2016 at Cineworld: The O2 Peninsula Square London SE10 0DX United Kingdom. The annual international summit will look at the various aspects of processes and research involved in ageing and senescence.
Akrotome Imaging Inc., a Cleveland-based medical imaging technology company, has received a major award from the National Institutes of Health (NIH) to complete development and commercialization of its leading-edge imaging platform.
The World Molecular Imaging Society (WMIS) presented the first annual Commercial Innovation of the Year Award at the 2015 World Molecular Imaging Congress (WMIC) to Frederik Beekman, CEO/CSO, MILabs for his work developing G-SPECT.
The ITM Group announced today that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a next generation theranostic agent for Bone Targeted Radionuclide Therapy and Diagnostics in patients suffering from bone metastases.